GENE ONLINE|News &
Opinion
Blog

2026-02-03|

BrightView Holdings Reports Revenue Growth and Improved Adjusted EBITDA for Q1 Fiscal 2026

by GOAI
Share To

BrightView Holdings, Inc. has released its financial results for the first quarter of fiscal year 2026, reporting an increase in top-line revenue and improved adjusted EBITDA. The company also reaffirmed its guidance for the full fiscal year 2026. These results reflect BrightView’s performance during the three-month period ending December 31, 2025.

The company reported growth in revenue compared to the same period in the previous fiscal year. Adjusted EBITDA, a key profitability metric that excludes certain non-recurring items, also showed improvement. BrightView stated that these outcomes align with its strategic objectives and operational focus for the year. Additionally, executives confirmed their confidence in achieving previously announced financial targets for fiscal 2026, maintaining their guidance despite broader economic conditions.

Further details on specific figures or contributing factors were not disclosed in this announcement.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: February 3, 2026

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
Lilly Acquires Orna Therapeutics in $2.4B to Scale In Vivo CAR-T Cell Therapies
2026-02-10
CCHH Receives Nasdaq Notice for Falling Below $1.00 Minimum Bid Price
2026-02-10
South African Patent Office Grants Manganese X Energy Corp. Patent for High-Purity Manganese Processing Technology
2026-02-10
Study Explores Impact of Symptoms on Health-Related Quality of Life in Older Swedish Men
2026-02-10
Study Finds Gaps in Support Systems for Parents Using At-Home Medical Devices for Children with Complex Needs
2026-02-10
Radiopharmaceutical Industry Faces Talent Shortage Amid Rapid Expansion
2026-02-10
FTI Consulting Expands Middle East Healthcare Advisory with Two Senior Hires
2026-02-09
EVENT
2026-02-09
World Health Expo Dubai
Dubai Exhibition Centre, Dubai
2026-02-17
BIO Asia 2026 (Life Science Partnerships)
Hyderabad, India
2026-02-24
Rare Disease Week on Capitol Hill (Policy and Advocacy)
Capitol Hill, Washington, D.C.
2026-03-09
HIMSS26 (Digital Health & Hospital IT)
Las Vegas, Nevada
2026-03-23
BIO Europe Spring (Biotech Partnering)
Lisbon, Portugal
Scroll to Top